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There are concerns over nonmedical use of prescription stimulants among youths, but little is known
about the extent of use among young Asian-Americans, Native Hawaiians/Paciﬁc Islanders (NHs/PIs), and
mixed-race individualsdthe fastest growing segments of the U.S. population. We examined prevalences
and correlates of nonmedical stimulant use (NMSU) and disorder (StiUD) for these underrecognized
groups. Whites were included as a comparison. Data were from young individuals aged 12e34 years in
the 2005e2012 National Surveys on Drug Use and Health. We used logistic regression to estimate odds of
past-year NMSU status. Signiﬁcant yearly increases in lifetime NMSU prevalence were noted in Whites
only. NHs/PIs (lifetime 7.33%, past-year 2.72%) and mixed-race individuals (10.20%, 2.82%) did not differ
from Whites in NMSU prevalence (11.68%, 3.15%). Asian-Americans (lifetime 3.83%, past-year 0.90%) had
lower prevalences than Whites. In each racial/ethnic group, “Methamphetamine/Desoxyn/Methedrine or
Ritalin” was more commonly used than other stimulant groups; “got them from a friend/relative for free”
and “bought them from a friends/relative” were among the most common sources. Females had greater
odds than males of NMSU (among White, NH/PI, mixed-race individuals) and StiUD (among mixed-race
individuals). Young adults (aged 18e25) had elevated odds of NMSU (White, NH/PI); adolescents had
elevated odds of StiUD (White, mixed-race). Other substance use (especially marijuana, other prescrip-
tion drugs) increased odds of NMSU and StiUD. NHs/PIs and mixed-race individuals were as likely as
Whites to misuse stimulants. Research is needed to delineate health consequences of NMSU and inform
prevention efforts for these understudied, rapidly-growing populations.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-SA
license (http://creativecommons.org/licenses/by-nc-sa/3.0/).1. Introduction
Asian-Americans, Native Hawaiians and other Paciﬁc Islanders
(NHs/PIs) in the United States are identiﬁed as vulnerable pop-
ulations as they tend to underutilize behavioral healthcare (IdaNSDUH, National Surveys on
ther Paciﬁc Islanders; NMSU,
Disorder; TEDS, Treatment
nd Behavioral Sciences, Duke
al Center, Box 3903, Durham,
þ1 919 681 8400.
an and Paciﬁc Islander Re-
A.
Ltd. This is an open access article uet al., 2012). Due to an array of factors‒such as limited English
proﬁciency, a lack of providers who have the language and cultural
skills needed to meet their healthcare needs, no insurance
coverage, or fears of immigration and deportation‒these pop-
ulations either have difﬁculties using healthcare timely or experi-
ence a high level of dissatisfactionwith the healthcare received (Ida
et al., 2012;Masson et al., 2013; Yu et al., 2009). In the United States,
an estimated 33% of adolescent Asian residents aged 12e17 years
nationally were born aboard (non US-born), and 81% of adult Asian
residents aged 18 years nationally were born aboard (Substance
Abuse and Mental Health Services Administration [SAMHSA],
2010, 2011). Asian-Americans and NHs/PIs face unique barriers to
seeking care related to substance use problems because of a lack of
culturally or linguistically congruent interventions and providers as
well as culture-related attitudes towards substance abuse andnder the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
L.-T. Wu et al. / Journal of Psychiatric Research 59 (2014) 189e199190treatment (shame, wanting to keep the problems within the family
to avoid disgrace), which may reduce treatment-seeking and
interferewith treatment engagement (Edwards et al., 2010; Masson
et al., 2013; Yu et al., 2009). Inadequate behavioral healthcare,
however, has adverse effects on the healthcare, education, welfare,
and justice systems and impacts the nation's economy (Institute of
Medicine, 2006). Adolescents and young adults are vulnerable to
substance-related adverse consequences; prevention interventions
are critical to reducing substance use problems. However, Asian-
Americans, NHs/PIs, and mixed-race individuals are vastly under-
represented in substance use prevention and treatment studies
(Korte et al., 2011; Rehuher et al., 2008); they are either excluded
from comparisons or pooled with other racial/ethnic groups. The
lack of epidemiological data on drug use impedes health policy and
prevention efforts.
Asian-Americans, NHs/PIs, and mixed-race (>1 race) population
are the fastest-growing segments of the U.S. population, growing in
numbers at 3e4 times the rate of the overall U.S. population (U.S.
Census Bureau, 2011). On average, these groups include higher
proportions of youths than the White population (Wu et al., 2013a,
2013b). Because substance use often starts in adolescence and in-
creases with age during the young adulthood (SAMHSA, 2013a), the
increase in their population sizes warrants research to determine
the extent of drug use to inform national Healthy People initiatives,
which also have the least amounts of empirical data available for
these groups (National Center for Health Statistics, 2012). Of note,
there have been concerns over nonmedical use of prescription
stimulants among youths (Arria and DuPont, 2010; Nagel and Graf,
2013). Depending on the survey samples, an estimated 5e35% of
college-aged young adults reported past-year nonmedical stimu-
lant use (NMSU) (Wilens et al., 2008). Studies of adolescents or
young adults suggest a high lifetime prevalence (range: 11e62%) of
diversion (selling, trading, giving away) of prescription stimulants
(Kaye and Darke, 2012). In a study of college students, 50% of the
sample perceived that “prescription stimulants are easy to get on
campus” (Weyandt et al., 2009). Nonmedical stimulant users
(NMSUs) were found to be more likely than non-users to have ac-
ademic, conduct, or substance use problems (Arria and DuPont,
2010; Bavarian et al., 2013; Lakhan and Kirchgessner, 2012;
Wilens et al., 2008). Repeated NMSU is associated with psychotic
symptoms or cardiovascular problems (Lakhan and Kirchgessner,
2012; McKetin et al., 2013). Recent data also show an increase in
prescription stimulanterelated emergency department visits
(SAMHSA et al., 2013b).
To date, little is known about the extent and correlates of NMSU
and stimulant use disorder (StiUD) among Asian-Americans, NHs/
PIs, and mixed-race individuals (Kaye and Darke, 2012). Existing
studies generally have not included an adequate number of Asian-
Americans, NHs/PIs, and mixed-race individuals to permit com-
parisons for each group. The national Monitoring the Future (MTF)
study found racial/ethnic differences in NMSU for three major
racial/ethnic groups (e.g., lifetime use prevalence among 12th
graders: 10.1% of Whites, 3.3% of Blacks, and 6.3% of Hispanics)
(Johnston et al., 2014). Greater access to stimulants for managing
attention deﬁcit hyperactivity disorder (ADHD) symptoms among
Whites than Blacks and Hispanics may contribute partly to greater
NMSU prevalences among Whites (Pastor and Reuben, 2005;
Stevens et al., 2005). However, MTF reports have not routinely
included drug use estimates for Asian-American, NH/PI, andmixed-
race students because of their small sample sizes in MTF studies
(Johnston et al., 2014). Smaller-scale studies of young individuals
(convenience, regional samples) are constrained by even smaller
sample sizes, excluding them from analyses of NMSU, StiUD, and
sources of stimulants.Stimulants are sometimes called “study” or “smart” drugs as
they are reported to be used as “cognitive enhancers” by students to
stay awake to study for exams or to improve academic performance
(Arria and DuPont, 2010; Bavarian et al., 2013). Reasons for NMSU
may include enhancing school performance, achieving euphoria, or
coping with stressors, suggesting that NMSU may affect youth of
various racial/ethnic backgrounds (Lakhan and Kirchgessner, 2012;
Rabiner et al., 2009). Compared with other racial/ethnic groups,
Asian-Americans generally report a higher level of personal and/or
(perceived) parental educational expectations for academic per-
formance, which, however, may be associated with parent-child
conﬂict, psychological stress, or emotional problems among
Asian-American youths (Castro and Rice, 2003; Qin et al., 2012a,
2012b; Saw et al., 2013). Given that prescription stimulants also
are perceived as safer than other illicit drugs (legal, information
about their effects available in package inserts), it is important to
determine the extent to which Asian-American youths are NMSUs
or manifest StiUD and their correlates (Arria and DuPont, 2010;
Quintero et al., 2006).
Moreover, treatment-seeking data suggest that Asian-
Americans and NHs/PIs may be more likely to misuse stimulants
than other drug classes. The Treatment Episode Data Set (TEDS)
reports, which track substance-related treatment admissions,
consider Asian-Americans and NHs/PIs as a single group (SAMHSA,
2012). In the TEDS, amphetamines and marijuana were the most
commonly identiﬁed classes of abused drugs for female Asian-
Americans/NHs/PIs (23%, 19% respectively) and male Asian-
Americans/NHs/PIs (17%, 21% respectively) (SAMHSA, 2012).
While research tends to show a low prevalence of substance use in
the pooled sample, analyses that speciﬁcally examine NHs/PIs ﬁnd
a higher prevalence of substance use and delinquency among NHs/
PIs than among Asian-Americans (Andrade et al., 2006; Lowry et al.,
2011; Wu et al., 2013c). Thus, it is important to examine Asian-
Americans and NHs/PIs separately for NMSU.
The TEDS reports omit mixed-race individuals because of
limited data. Mixed-race individuals also are under-represented in
the drug use prevention research (Rehuher et al., 2008). During the
past decade, mixed-race groups grew in number at least 3 times
faster than single-race groups; mixed-race individuals are on
average younger and ﬁnancially poorer than Whites (U.S. Census
Bureau, 2011; Wu et al., 2013a, 2013b). Moreover, mixed-race in-
dividuals are similar toWhites in tobacco use prevalence but higher
than Whites in any drug use prevalence (Wu et al., 2013a, 2013b).
The growing populations of young Asian-American, NH/PI, and
mixed-race individuals, along with increased availability of stim-
ulants and stimulant-related emergency department admissions,
warrant research to characterize factors associated with NMSU and
StiUD and sources of stimulants to inform research (Setlik et al.,
2009; SAMHSA et al., 2013b).
Here, we examined not only the prevalence and correlates of
past-year NMSU but also past-year StiUD and the types and sources
of stimulants used to address the lack of such data. To mitigate
constraints of the sample size, we analyzed datasets from national
samples of Asian-Americans, NHs/PIs, and mixed-race individuals
using the National Surveys on Drug Use and Health (NSDUH). The
independent, cross-sectional 2005e2012 NSDUH used similar de-
signs, allowing analysis of the same variables from the pooled
sample to determine correlates of NMSU and StiUD. While prior
research has focused exclusively on either adolescents (12e17
years) or college-aged individuals (18e25 years), we examined data
from adolescents and adults aged 12e34 years to evaluate age-
related differences in NMSU and StiUD. Given age-related in-
crease in academic work demand and the likelihood of afﬁliating
with substance-using peers, we examined whether NMSU
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years in these understudied, nonwhite groups (Lakhan and
Kirchgessner, 2012). White race is considered risk correlate for
NMSU (Kaye and Darke, 2012); we includedwhites to inform racial/
ethnic disparity analyses.
2. Methods
2.1. Data source
Weanalyzed public-use datasets from the 2005e2012NSDUH to
characterize NMSU and StiUD, with a focus on individuals aged
12e34who showed greater past-year NMSUprevalences than older
adults (SAMHSA, 2013b). NSDUH is the national survey designed to
provide ongoing estimates of drug use in the United States
(SAMHSA, 2006, 2013b). The 2005e2012 surveys used multistage
area probability samplingmethods to select a representative sample
of the civilian, noninstitutionalized population aged 12 years.
Residents of households from the 50 states (including shelters,
rooming houses, and group homes) and civilians residing on mili-
tary bases were included. The design oversampled individuals aged
12e25 years. Due to a large sample size, there was no need to
oversample racial/ethnic groups, as was done before 1999.
After carefully explaining all study procedures and protections,
respondents were interviewed in their homes for about an hour.
Respondents were assured that their names would not be recorded
and their responses would be kept strictly conﬁdential. De-
mographic data were assessed by computer-assisted personal in-
terviews. Substance use questions were assessed using a computer-
assisted self-interviewmethod. The latter was designed to increase
honest reporting of substance use by allowing respondents to either
read the questions on a computer screen or listen to the questions
read aloud by the computer through headphones, and then enter
their responses directly into the computer (Turner et al., 1998).
NSDUH's annual sample was considered representative of the
U.S. general population aged 12 years. To include adequate
numbers of Asian-Americans, NHs/PIs, and mixed-race individuals
to detect meaningful racial/ethnic differences in drug use, we
pooled the public-use datasets from 2005 to 2012 (n ¼ 55,279 to
58,379/year); weighted response rates of household screening and
interviewing were 86e91% and 73e76%, respectively (SAMHSA,
2006, 2013b). The pooled analysis sample included 12,335 Asian-
Americans, 1729 NHs/PIs, 11,882 mixed-race individuals as well as
203,759 Whites aged 12e34 years (N ¼ 229,705).
2.2. Study variables
Self-reported race/ethnicity, age, sex, annual household income,
government assistance, and county type were included in logistic
regression analyses to account for race/ethnicity-related differ-
ences in sociodemographics (Duncan et al., 2002; Wilson and
Donnermeyer, 2006). Based on respondents' self-reported re-
sponses to race and ethnicity questions, NSDUH deﬁned mutually
exclusive groups: non-Hispanic Whites, non-Hispanic Asian-
Americans (Asian Indian, Chinese, Filipino, Japanese, Korean, Viet-
namese), non-Hispanic NHs/PIs, and mixed-race individuals (>1
race). The public-use datasets do not distinguish between speciﬁc
racial groups of mixed-race individuals. In the United States, the
majority of mixed-race individuals (82%) were White in combina-
tion with another race (Black, Asian-American, Native American,
other race). NHs/PIs (55.9%), Asian-Americans (15.3%), and Native
Americans (43.8%) included high proportions of mixed-race in-
dividuals (U.S. Census Bureau, 2011).
Drug use was assessed using separate questions to assess re-
spondents' nonmedical use (i.e., not prescribed for the respondentor taken only for the experience or feeling it caused) of each drug
class, including a detailed description of each drug group and lists
of qualifying drugs. NMSU included the following categories: (1)
methamphetamine, Desoxyn®, or Methedrine; (2) amphetamines,
Benzedrine®, Biphetamine, Fastin®, or phentermine; (3) Ritalin® or
methylphenidate; (4) Cylert®; (5) Dexedrine®; (6) dextroamphet-
amine; (7) Didrex®; (8) Eskatrol®; (9) Ionamin®; (10) Mazanor®;
(11) Obedrin-LA®; (12) Plegine®; (13) Preludin®; (14) Sanorex®; and
(15) Tenuate®. Methamphetamine use may be underestimated
when its use questions are included within questions about pre-
scription drugs; beginning in 2005, NSDUH has added additional
descriptions to capture methamphetamine use. Past-year DSM-IV
StiUD included abuse of or dependence on stimulants (American
Psychiatric Association, 2000).
Behavioral health problems are associatedwith NMSU (Arria and
DuPont, 2010; Wilens et al., 2008). We examined whether such in-
dicators were associated with NMSU among Asian-Americans, NHs/
PIs, and mixed-race individuals. Past-year alcohol use, past-year to-
bacco use (cigarettes, cigars, smokeless tobacco, pipe tobacco), past-
year marijuana use, past-year nonmedical use of other prescription
drugs (pain relievers, sedatives, tranquilizers), past-year DSM-IV
major depressive episode (MDE) (Kessler et al., 2005), and past-year
arrest status (i.e., arrested and booked for breaking the law) were
included as covariates (Bennett et al., 2008; Wu et al., 2008, 2013b).
We used updated public-use data released in 2013 because they
permitted pooled analyses of MDE variables from 2005 to 2012.
2.3. Data analysis
We examined racial/ethnic differences in sociodemographics,
substance use status, MDE, and arrest status. We determined types
and sources of stimulants used. We conducted logistic regression
analyses of the pooled sample to determine racial/ethnic differ-
ences in odds of NMSU and StiUD when adjusting for age, sex,
household income, government assistance, county type, MDE, ar-
rest status, past-year substance use (alcohol, tobacco, marijuana
use, nonmedical use of other prescription drugs), and survey year to
lessen for their confounding effects. Finally, we examined corre-
lates of NMSU and StiUD for each racial/ethnic group. All analyses
took into account NSDUH's complex designs, such as weighting and
clustering (RTI International, 2008). All results are weighted except
for sample sizes (unweighted). Because of using population-based
data, we focused on prevalence estimates; 95% conﬁdence in-
tervals (CI) are reported to ease interpretation.
3. Results
3.1. Sociodemographics and behavioral health (Table 1)
There were more NHs/PIs and mixed-race individuals than
Whites in the lowest-income and receiving government assistance
groups. Mixed-race individuals had the highest prevalence (annual
average) of past-year MDE (11.50%), arrest (5.96%), and marijuana
use (25.94%). Whites had the highest prevalence of past-year to-
bacco (46.82%) and alcohol (70.85%) use. Asian-Americans had the
lowest prevalence of MDE (5.22%), arrest (1.31%), tobacco use
(23.37%), alcohol use (53.61%), marijuana use (9.14%), and other
nonmedical prescription drug use (3.99%). Mixed-race individuals
(10.92%) and Whites (11.72%) had higher prevalences of other
nonmedical prescription drug use than NHs/PIs (6.62%).
3.2. Prevalence of stimulant use and disorder (Table 1)
NHs/PIs (7.33%), mixed-race (10.20%), and Whites (11.68%) had
higher lifetime NMSU prevalences than Asian-Americans (3.83%).
Table 1
Selected characteristics of non-Hispanic Whites, non-Hispanic Asian-Americans, non-Hispanic Native Hawaiians/Paciﬁc Islanders, and non-Hispanic mixed-race individuals
aged 12e34: 2005e2012 (Unweighted N ¼ 229,705).
Weighted proportion, % 95% CI White N ¼ 203,759 Asian American
N ¼ 12,335
Native Hawaiian/Paciﬁc
Islander N ¼ 1729
Mixed-race N ¼ 11,882
% 95% CI % 95% CI % 95% CI % 95% CI
Age in years
12e17 26.07 25.77e26.38 22.52 21.22e23.88 22.68 19.79e25.86 35.70 34.02e37.42
18e25 35.96 35.52e36.41 32.99 31.55e34.46 38.37 34.57e42.32 34.52 32.79e36.28
26e34 37.96 37.48e38.45 44.49 42.81e46.18 38.95 34.77e43.31 29.78 27.27e32.43
Sex
Male 50.27 49.89e50.65 49.13 47.80e50.46 50.40 45.33e55.47 47.74 45.67e49.82
Female 49.73 49.35e50.11 50.87 49.54e52.20 49.60 44.53e54.67 52.26 50.18e54.33
Household income
<$50,000 48.84 48.30e49.38 48.61 46.28e50.94 59.16 54.18e63.96 58.78 56.85e60.69
$50,000e$74,999 19.05 18.76e19.35 17.62 16.37e18.94 19.02 15.73e22.82 17.22 15.59e18.98
$75,000þ 32.11 31.66e32.56 33.77 31.66e35.96 21.82 18.06e26.11 24.00 22.20e25.89
Government assistance
Yes 14.90 14.58e15.21 9.93 8.93e11.03 22.14 18.61e26.11 26.65 24.70e28.69
County type
Large metro 45.07 44.35e45.78 76.05 74.42e77.60 57.70 52.92e62.34 47.98 46.17e49.79
Small metro 47.58 46.78e48.37 23.30 21.75e24.92 41.28 36.77e45.95 48.29 46.51e50.08
Nonmetro 7.36 6.98e7.75 0.65 0.48e0.89 1.01 0.47e2.18 3.73 3.18e4.37
Being arrested/booked
Past-year 4.49 4.34e4.64 1.31 1.09e1.57 4.69 3.34e6.56 5.96 5.05e7.03
Major depressive episode
Past-year 8.85 8.65e9.05 5.22 4.62e5.88 7.43 5.89e9.33 11.50 10.12e13.03
Tobacco use
Past-year 46.82 46.38e47.27 23.37 22.05e24.74 36.77 32.99e40.73 42.77 41.17e44.39
Alcohol use
Past-year 70.85 70.51e71.18 53.61 51.84e55.38 62.42 57.43e67.16 64.72 62.91e66.49
Marijuana use
Past-year 22.15 21.81e22.49 9.14 8.34e10.00 18.20 15.43e21.34 25.94 24.07e27.90
Nonmedical use of pain relievers, sedatives, or tranquilizers
Past-year 11.72 11.48e11.97 3.99 3.47e4.59 6.62 5.06e8.61 10.92 9.77e12.18
Stimulant use
Past-year 3.15 3.05e3.25 0.90 0.68e1.18 2.72 1.19e6.09 2.82 2.26e3.51
Lifetime 11.68 11.41e11.97 3.83 3.26e4.49 7.33 4.58e11.52 10.20 9.02e11.50
Stimulant use disorder
Past-year 0.40 0.36e0.45 0.12 0.07e0.21 0.19 0.07e0.54 0.30 0.22e0.42
Note: CI: conﬁdence interval. Boldface: The estimate differed from the estimate among Whites. Due to the sample size, results for Native Hawaiians/Paciﬁc Islanders are
considered preliminary.
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past-year NMSUprevalences than Asian-Americans (0.90%). Mixed-
race individuals (0.30%) and Whites (0.40%) had higher past-year
StiUD prevalences than Asian-Americans (0.12%); the latter preva-
lence was similar to NHs/PIs (0.19%). NHs/PIs and mixed-race in-
dividuals did not differ from Whites in NMSU and StiUD
prevalences. In each group (data not shown in a table), past-year
NMSU was more prevalent in the 18e25 age group than 12e17
and 26e34 age groups (p < 0.01 for each comparison: White 1.93%
[12e17 years], 4.96% [18e25 years], 2.27% [26e34 years], respec-
tively; Asian-American 0.66%, 1.67%, 0.44%, respectively; NH/PI
0.37%, 4.10%, 2.73%,respectively; mixed-race 1.77%, 3.87%,
2.87%,respectively).
Among past-year stimulant users, there were no signiﬁcant
differences in past-year StiUD prevalence (12.69% with StiUD in
White users, 13.27% in Asian-American users, 7.6% in NH/PI users,
10.71% in mixed-race users; p > 0.05) and the mean number of days
of using nonmedical stimulants (White 46.55 days/year, Asian-
American 57.64 days/year, NH/PI 72.38 days/year, mixed-race
45.73 days/year; p > 0.05).3.3. Types of stimulants used (Table 2)
Among lifetime NMSU, we examined types of stimulants. There
were no racial/ethnic differences in use of “methamphetamine/
Desoxyn/Methedrine” (White 39.15%, Asian-American 44.79%, NH/PI 60.64%, mixed-race 41.07%). Compared with Whites (45.49%),
fewer Asian-Americans (34.23%) and NHs/PIs (14.87%) used
“Ritalin/methylphenidate”; mixed-race individuals (39.23%)
resembled Whites. Fewer Asian-Americans (13.74%) than Whites
(20.51%) used “amphetamines/benzedrine/Biphetamine/Fastin/
phentermine”; NHs/PIs (12.27%) and mixed-race individuals
(24.90%) resembled Whites. More Whites than NHs/PIs used
Dexedrine (5.11% vs. 0.54%) and dextroamphetamine (3.36% vs.
0.16%). Across racial/ethnic groups, few (<7%) used other groups of
stimulants.3.4. Sources of stimulants used among NMSUs (on-line only
Table 1)
Commonly endorsed sources of prescription stimulants
included: “got it from a friend/relative for free” (White 54.17%,
Asian-American 55.02%, NH/PI 10.44%, mixed-race 48.74%) and
“bought it from a friend/relative” (White 21.68%, Asian-American
18.26%, NH/PI 63.58%, mixed-race 17.76%). The next sources were
“got it from one doctor” (7.43e11.08%), “bought it from a drug
dealer/stranger” (6.69e10.45%), “took it from a friend/relative
without asking” (2.97e5.52%), and “bought it on the Internet”
(0e4.52%). Very few (0e2.19%) reported “got it from 2 or more
doctors,” “wrote fake prescription,” or “stole from doctor's ofﬁce/
clinic/hospital/pharmacy.”
Table 2
Stimulants used by lifetime nonmedical prescription stimulant users aged 12e34 years, stratiﬁed by race/ethnicity.
Stimulants used Lifetime nonmedical prescription stimulant users aged 12e34 years
Unweighted N White N ¼ 19,231 Asian American
N ¼ 443
Native Hawaiian/
Paciﬁc Islander
N ¼ 103
Mixed-race N¼ 1026
% 95% CI % 95% CI % 95% CI % 95% CI
Weighted proportion, column %
Methamphetamine, Desoxyn, or Methedrine 39.15 37.76e40.55 44.79 36.91e52.94 60.64 39.36e78.52 41.07 34.71e47.75
Amphetamines, Benzedrine®, Biphetamine®, Fastin®, or phentermine 20.51 19.69e21.35 13.74 9.69e19.13 12.27 6.78e21.20 24.90 19.29e31.50
Ritalin® or methylphenidate 45.49 44.21e46.78 34.23 27.46e41.70 14.87 7.69e29.86 39.23 33.24e45.55
Cylert® 0.75 0.60e0.94 0.38 0.09e1.56 0.65 0.15e2.81 1.16 0.45e2.96
Dexedrine® 5.11 4.66e5.61 3.17 1.68e5.92 0.54 0.10e2.92 6.87 3.25e13.95
Dextroamphetamine 3.36 3.04e3.71 2.70 1.37e5.26 0.16 0.02e1.16 4.02 2.36e6.76
Didrex® 0.56 0.40e0.77 0.31 0.08e1.10 1.19 0.20e6.81 0.68 0.19e2.42
Eskatrol® 0.31 0.22e0.43 0.44 0.11e1.77 0.16 0.02e1.16 0.18 0.04e0.72
Ionamin® 0.37 0.26e0.54 0.71 0.24e2.13 0.16 0.02e1.16 0.31 0.11e0.92
Mazanor® 0.17 0.13e0.24 0.43 0.08e2.31 0.16 0.02e1.16 0.72 0.17e2.90
Obedrin-LA® 0.14 0.08e0.23 0 0.16 0.02e1.16 0.01 0.00e0.08
Plegine® 0.22 0.14e0.35 0 0.16 0.02e1.16 0.70 0.16e2.89
Preludin® 0.46 0.35e0.60 0.09 0.02e0.40 0.16 0.02e1.16 0.14 0.05e0.38
Sanorex® 0.43 0.34e0.54 0.10 0.01e0.74 0.16 0.02e1.16 0.94 0.42e2.10
Tenuate® 0.33 0.21e0.52 0 0.16 0.02e1.16 0.22 0.04e1.16
Other stimulants 24.32 23.45e25.21 20.68 15.81e26.57 12.42 5.18e26.93 25.00 19.70e31.18
Number of prescription stimulant drug classes used, lifetime
One 67.08 65.94e68.20 75.08 67.37e81.47 74.40 54.11e87.75 61.98 54.10e69.28
Two or more stimulant classes 32.92 31.80e34.06 24.92 18.53e32.63 25.60 12.25e45.89 38.02 30.72e45.90
Note: The analysis is based on lifetime stimulant users who reported the types of stimulants ever used.
Because of a small number, results for Native Hawaiians/Paciﬁc Islanders are considered preliminary.
CI: conﬁdence interval. Bold face: The estimate differed from the estimate amongWhites. Due to the sample size, results for Native Hawaiians/Paciﬁc Islanders are considered
preliminary.
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We conducted logistic regression analyses to adjust for poten-
tially confounding inﬂuences (age, sex, household income, county
type, government assistance, MDE, arrest, alcohol use, tobacco use,
marijuana use, other nonmedical drug use, survey year) on the
estimates of racial/ethnic differences in past-year NMSU and past-
year StiUD.
NMSU: Compared with Whites, Asian-Americans had lower
odds of NMSU (adjusted odds ratio [AOR] 0.73, 95% CI¼ 0.55e0.97);
NHs/PIs and mixed-race individuals resembled Whites in odds of
NMSU.
StiUD: Compared with Whites, mixed-race individuals had
lower odds of StiUD (AOR 0.68, 95% CI ¼ 0.46e0.99); Asian-
Americans and NHs/PIs resembled Whites in odds of StiUD.
StiUD among past-year NMSU: There were no racial/ethnic dif-
ferences in StiUD among NMSUs.3.6. Correlates of past-year NMSU (Table 4)
Asian-Americans: Substance use (tobacco, alcohol, marijuana,
other prescription drugs) increased odds of NMSU.
NHs/PIs: Age 18 years (vs. 12e17), female sex, other nonmed-
ical prescription drug use increased odds of NMSU.
Mixed-race individuals: Female sex and substance use (tobacco,
marijuana, other prescription drugs) increased odds of NMSU.3.7. Correlates of past-year StiUD (Table 5)
Asian-Americans: Substance use (tobacco, marijuana, other
prescription-drugs) increased odds of StiUD.
NHs/PIs: Age 18 years and marijuana use increased odds of
StiUD.Mixed-race individuals: Ages 12e17 (vs. 26e34), female sex,
small metropolitan residence, and substance use (tobacco, mari-
juana, other prescription drugs) increased odds of StiUD.
3.8. Correlates of past-year StiUD among NMSUs
We conducted adjusted logistic regression to identify correlates
of StiUD among past-year NMSU (on-line only Table 2). Among
White NMSU, being aged 12e17 (vs. aged 18e25), arrest, MDE, and
nonmedical use of other prescription drugs increased odds of
having a StiUD. Among Asian-American NMSUs, marijuana use
increased odds of having a StiUD. Among mixed-race NMSUs, fe-
males had greater odds thanmales of having a StiUD. Analyseswere
not included for NHs/PIs due to a small sample of past-year NMSUs.
4. Discussion
NMSU has been understudied in Asian-American, NH/PI, and
mixed-race populations. These results have timely implications for
research and prevention efforts. First, on average, mixed-race in-
dividuals exhibited the highest prevalence of past-yearMDE, arrest,
and marijuana use; Whites had the highest prevalence of past-year
tobacco and alcohol use. Second, NHs/PIs and mixed-race in-
dividuals had similar prevalences of NMSU and StiUD as Whites,
while Asian-Americans had lower prevalences. Third, in each racial/
ethnic group, “methamphetamine/Desoxyn/Methedrine” and
“Ritalin” were commonly used; “got it from a friend/relative for
free” and “bought it from a friend/relative”were primary sources of
stimulants. Fourth, females had greater odds than males of NMSU
(White, NH/PI, mixed-race) and StiUD (mixed-race). Young adults
aged 18e25 years (vs. 12e17) had elevated odds of NMSU (White,
NH/PI); adolescents (vs. 26e34 years) had elevated odds of NMSU
(White, NH/PI) and StiUD (White, mixed-race). Past-year substance
use (marijuana, other prescription drugs) increased odds of NMSU
and StiUD.
Table 3
Racial/ethnic differences in past-year nonmedical stimulant use and stimulant use disorder in the sample and past-year stimulant use disorder among past-year stimulant
users (Unweighted N ¼ 229,705).
Adjusted logistic regression Nonmedical stimulant use1 Stimulant use disorder1 Stimulant use disorder
among stimulant users1
Adjusted odds ratios AOR 95% CI AOR 95% CI AOR 95% CI
Race/ethnicity (vs. White)
Asian American 0.73 0.55e0.97 1.03 0.57e1.85 1.48 0.76e2.89
Native Hawaiian/Paciﬁc Islander 1.33 0.53e3.35 0.81 0.28e2.37 0.73 0.22e2.45
Mixed-Race 0.85 0.65e1.12 0.68 0.46e0.99 0.83 0.50e1.38
Age (vs. 12e17 years)
18e25 1.14 1.05e1.23 0.81 0.65e1.01 0.74 0.57e0.94
26e34 0.81 0.71e0.92 0.68 0.50e0.93 0.80 0.56e1.13
Sex (vs. female)
Male 0.78 0.72e0.84 0.81 0.64e1.04 0.96 0.76e1.22
Household Income (vs. $75,000þ)
<$50,000 1.05 0.95e1.16 0.82 0.63e1.05 0.82 0.62e1.09
$50,000e$74,999 0.88 0.77e1.00 0.75 0.53e1.07 0.85 0.56e1.29
Government assistance (vs. no)
Yes 1.01 0.91e1.12 1.15 0.91e1.45 1.17 0.90e1.51
County type (vs. large metro)
Small metro 0.99 0.91e1.08 1.02 0.81e1.29 1.07 0.83e1.38
Nonmetro 1.02 0.87e1.19 0.95 0.67e1.34 0.97 0.69e1.38
Being arrested/booked (vs. no)
Past-year 1.63 1.43e1.85 2.31 1.83e2.92 1.65 1.31e2.08
Major depressive episode (vs. no)
Past-year 1.59 1.46e1.73 3.30 2.57e4.25 2.53 1.93e3.32
Tobacco use (vs. no)
Past-year use 2.08 1.81e2.39 2.11 1.33e3.35 1.14 0.71e1.83
Alcohol use (vs. no)
Past-year use 2.88 2.41e3.43 2.89 1.82e4.58 1.06 0.66e1.70
Marijuana use (vs. no)
Past-year use 3.78 3.34e4.27 2.36 1.77e3.14 0.82 0.61e1.10
Nonmedical use of pain relievers, sedatives, or tranquilizers (vs. no)
Past-year use 5.42 5.02e5.86 10.53 8.02e13.81 2.27 1.75e2.94
Survey year (vs. 2005)
2006 1.21 1.04e1.41 0.96 0.62e1.48 0.86 0.54e1.38
2007 0.97 0.82e1.14 0.85 0.57e1.29 0.94 0.59e1.51
2008 1.02 0.85e1.21 0.92 0.60e1.43 0.97 0.61e1.55
2009 0.90 0.77e1.05 0.88 0.58e1.32 1.04 0.65e1.65
2010 0.95 0.83e1.08 0.88 0.55e1.38 0.98 0.60e1.59
2011 0.88 0.75e1.04 0.85 0.58e1.25 1.00 0.65e1.54
2012 1.17 1.01e1.35 1.46 1.08e1.96 1.38 0.96e2.00
Note: AOR: adjusted odds ratio; CI: conﬁdence interval. 1 Each adjusted logistic regression included all variables listed in the ﬁrst column. Due to the sample size, results for
Native Hawaiians/Paciﬁc Islanders are considered preliminary. The boldface indicates P < 0.05.
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Research on NMSU focuses mainly on college students and
frequently does not include sufﬁcient numbers of Asian-Americans,
NHs/PIs, and mixed-race individuals for comparison; Whites
generally show greater odds of NMSU than nonwhites (Arria and
DuPont, 2010). This analysis of a large national sample allowed a
more careful examination of non-white groups and revealed that
NHs/PIs and mixed-race individuals are as likely as Whites to use
stimulants nonmedically. Moreover, individuals who self-identify
as mixed-race and Whites have the highest prevalences of past-
year nonmedical use of other prescription drugs. The proportion
of individuals living in lower-income households or receiving
government assistance is much higher in young mixed-race in-
dividuals as compared to Whites. Because lower socioeconomic
status, associated stress, and poor behavioral and mental health
may interact to intensify behavioral health problems (DuRant et al.,
1999; O'Neil et al., 2011), the ﬁndings suggest that the growing
mixed-race population may be vulnerable to experiencing drug
use-related problems. Prior results from the National Survey of
Children's Health (10e17 years) showed mixed-race children
experiencing a higher prevalence of “difﬁculty with emotions,
behavior, or interpersonal relations,” and “not receiving the needed
medical care” than White children (Lau et al., 2012). Data fromtreatment-seeking populations also demonstrate mixed-race in-
dividuals presenting a more severe pattern of substance use and
mental disorders than Asian-Americans (Wu et al., 2013c).
Since 2000, the US census has provided an option to allow in-
dividuals to self-identify with more than one race. Between 2000
and 2010, themixed-race population is growing at least three times
faster than single-race population and that white-Black, white-
Asian, andwhite-native American constitute the largestmixed-race
subgroups (U.S. Census Bureau, 2011). NSDUH follows federal
standards to collect the mixed-race status. While it is unclear about
the reliability of mixed-race classiﬁcation in the national surveys,
the growing numbers of mixed-race individuals and their key de-
mographics (younger, poorer than Whites) are generally consistent
across reports (Lau et al., 2012; Macartney 2011; Wang, 2012). The
Healthy People 2010 Final Review reports reveal that mixed-race as
well as Asian-American and NH/PI individuals have the least reli-
able data available to evaluate their health indicators (National
Center for Health Statistics, 2012). The NIH (2013, 2014) requires
collection and reporting of the mixed-race status in the enrollment
of individuals involved in clinical research. Collectively, research
efforts are needed to better evaluate the magnitude of differences
in behavioral health acrossmixed-race subgroups, assess the role of
enculturation (endorsing a givenminority group) and acculturation
(adopting the predominant white culture) in behavioral (conduct,
Table 4
Adjusted odds ratios of past-year nonmedical prescription stimulant use, stratiﬁed by race/ethnicity (Unweighted N ¼ 229,705).
Adjusted logistic regressiona White N ¼ 203,759 Asian American
N ¼ 12,335
Native Hawaiian/Paciﬁc
Islander N ¼ 1729
Mixed-race N ¼ 11,882
AOR 95% conﬁdence interval AOR 95% CI AOR 95% CI AOR 95% CI AOR 95% CI
Age (vs. 12e17 years)
18e25 1.13 1.04e1.22 1.06 0.52e2.15 11.47 2.33e56.32 1.35 0.86e2.10
26e34 0.80 0.71e0.91 0.54 0.25e1.18 13.58 2.45e75.39 1.45 0.76e2.77
Sex (vs. female)
Male 0.80 0.73e0.86 0.79 0.44e1.42 0.18 0.04e0.86 0.44 0.30e0.65
Household Income (vs. $75Kþ)
<$50,000 1.03 0.94e1.14 1.67 0.81e3.46 3.84 0.35e42.20 1.11 0.69e1.79
$50,000e$74,999 0.87 0.76e0.99 0.76 0.37e1.55 eb 1.39 0.58e3.36
Government assistance (vs. no)
Yes 1.02 0.92e1.14 0.91 0.42e1.95 0.46 0.12e1.71 1.09 0.56e2.14
County type (vs. large metro)
Small metro 0.98 0.89e1.07 1.45 0.86e2.47 0.53 0.15e1.87 1.69 0.91e3.14
Nonmetro 1.01 0.86e1.19 2.30 0.60e8.78 ec 1.09 0.46e2.60
Being arrested/booked (vs. no)
Past-year 1.64 1.43e1.87 1.72 0.61e4.86 0.66 0.10e4.42 1.57 0.94e2.62
Major depressive episode (vs. no)
Past-year 1.62 1.48e1.76 1.70 0.84e3.43 1.16 0.27e4.93 1.02 0.63e1.67
Tobacco use (vs. no)
Past-year use 1.98 1.72e2.28 3.54 1.84e6.80 ed 2.98 1.43e6.20
Alcohol use (vs. no)
Past-year use 3.20 2.65e3.85 1.78 1.03e3.08 1.18 0.07e19.43 1.16 0.38e3.55
Marijuana use (vs. no)
Past-year use 3.84 3.39e4.35 2.78 1.52e5.07 2.57 0.80e8.25 4.07 2.28e7.28
Nonmedical use of pain relievers, sedatives, or tranquilizers (vs. no)
Past-year use 5.43 5.03e5.87 6.82 3.51e13.27 7.24 2.17e24.09 4.43 2.80e7.01
Survey year (vs. 2005)
2006 1.17 1.00e1.37 2.29 0.84e6.22 ed 1.82 0.56e5.98
2007 0.94 0.79e1.12 1.70 0.52e5.57 e 0.77 0.33e1.80
2008 1.02 0.85e1.22 1.14 0.36e3.59 e 1.22 0.72e2.05
2009 0.89 0.76e1.04 1.44 0.47e4.38 e 1.05 0.57e1.93
2010 0.96 0.83e1.11 0.98 0.39e2.45 e 0.44 0.24e0.82
2011 0.89 0.75e1.05 0.56 0.19e1.67 e 0.89 0.47e1.66
2012 1.19 1.03e1.38 1.34 0.47e3.77 e 0.68 0.36e1.28
Note: AOR: adjusted odds ratio; CI: conﬁdence interval. Because of a small number, results for Native Hawaiians/Paciﬁc Islanders are considered preliminary. The boldface
indicates P < 0.05.
a Each adjusted logistic regression included all variables listed in the ﬁrst column.
b The two groups (family income <$75,000) were combined due to a small cell size.
c The two groups (small metro, nonmetro) were combined due to a small cell size.
d The variable was not included in the model due to a small cell size. Due to the sample size, results for Native Hawaiians/Paciﬁc Islanders are considered preliminary.
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cioeconomic factors and parenting practices in protecting mixed-
race youth from psychopathology (Blanco et al., 2013; Burnett-
Zeigler et al., 2013; DeVore and Ginsburg, 2005; Hawkins et al.,
1992; Watkins and Ford, 2011).
This study also includes new data on types of stimulants used
and sources of stimulants (diversion) for Asian-Americans, NHs/
PIs and mixed-race individuals. Similar to white NMSUs, the
majority (62e75%) of Asian-American, NH/PI, or mixed-race
NMSUs used one group of stimulants from either “Ritalin/meth-
ylphenidate,” “methamphetamine/desoxyn/methedrine,” or
“amphetamines/benzedrine/biphetamine/fastin/phentermine.”
Hence, the stimulant of the choice appears to be stable, and
commonly used stimulants should be the focus for prevention
and surveillance efforts. Regardless of race/ethnicity, common
sources of prescription stimulants were “getting it from a friend/
relative for free” and “buying it from a friend/relative.” Fewer
reports of NMSU (0e11%) endorsed other sources (doctor, fake
prescription, stealing, drug dealer, Internet). Surveys of college
students found peers as the primary source (Bavarian et al., 2013;
McCabe and Boyd, 2005; McNiel et al., 2011). The data from ad-
olescents suggest that either medical or nonmedical stimulant
users were approached to give away, loan, trade, or sell their
stimulants (McCabe et al., 2011). Collectively, sharing or selling
stimulants may be common among NMSUs. Future researchshould determine whether sharing or selling stimulants re-
inforces drug use behaviors, shapes perceived norms of
nonmedical use, or promotes drug-using social networks
(McCabe, 2008; Neighbors et al., 2006; Perkins et al., 2005).
This study expands prior research by covering a wider age range
to delineate aged-related differences in NMSU. Adolescents were
more likely than adults aged 26e34 to engage in NMSU (mainly
Whites) or have StiUD (mainlyWhites andmixed-race individuals).
Among past-year NMSU, adolescents were more likely than young
adults aged 18e25 to have StiUD. Given that most NMSU studies
examine college students, there is a need for in-depth research on
adolescents' use patterns and motives (e.g., lose weight, self-
medicate negative affect, get high), including reasons that lead to
StiUD (Kaye and Darke, 2012; McCabe and Cranford, 2012). For
example, use of stimulants as “study drugs” by some college stu-
dents may not be applicable to adolescents. Additionally, race/
ethnicity-speciﬁc analyses indicated that NMSU was more likely
to be in adults aged 18e34 than in adolescents among NHs/PIs only,
which may be related to the sources of stimulants. Of the four
racial/ethnic groups, NHs/PIs reported the highest proportion of
“buying stimulants from a friend/relative” and the lowest propor-
tion of “getting stimulants from a friend/relative for free.” Future
research could examine whether prescription stimulants are less
accessible to NH/PI adolescents than for other racial/ethnic groups
(e.g., whether NHs/PIs are less likely to get stimulants prescribed
Table 5
Adjusted odds ratios of past-year stimulant use disorder, stratiﬁed by race/ethnicity (Unweighted N ¼ 229,705).
Adjusted logistic regressiona White N ¼ 203,759 Asian American
N ¼ 12,335
Native Hawaiian/Paciﬁc
Islander N ¼ 1729
Mixed-race N ¼ 11,882
AOR and 95% conﬁdence intervals AOR 95% CI AOR 95% CI AOR 95% CI AOR 95% CI
Age (vs. 12e17 years)
18e25 0.81 0.64e1.02 0.5 0.12e2.85 1.30 1.19e1.43 0.87 0.40e1.91
26e34 0.70 0.51e0.95 eb eb 0.22 0.05e0.95
Sex (vs. female)
Male 0.85 0.66e1.10 0.43 0.10e1.82 0.57 0.11e2.88 0.22 0.11e0.44
Household Income (vs. $75,000þ)
<$50,000 0.83 0.64e1.07 0.54 0.11e2.66 ed 0.53 0.16e1.74
$50,000e$74,999 0.73 0.51e1.05 1.82 0.43e7.62 ed 0.45 0.12e1.73
Government assistance (vs. no)
Yes 1.14 0.91e1.44 1.80 0.46e7.09 5.71 0.32e101.69 0.74 0.25e2.26
County type (vs. large metro)
Small metro 1.00 0.79e1.27 1.03 0.28e3.75 0.80 0.05e12.66 3.46 1.05e11.44
Nonmetro 0.96 0.67e1.36 ec ec 0.78 0.14e4.41
Being arrested/booked (vs. no)
Past-year 2.24 1.76e2.86 ed ed 1.42 0.51e3.98
Major depressive episode (vs. no)
Past-year 3.39 2.62e4.39 1.69 0.32e9.03 1.87 0.36e9.74 1.89 0.43e8.19
Tobacco use (vs. no)
Past-year use 1.99 1.23e3.19 14.01 2.04e96.16 0.73 0.11e4.92 4.95 2.00e12.23
Alcohol use (vs. no)
Past-year use 3.44 2.20e5.37 0.34 0.04e3.07 ed 2.70 0.81e8.99
Marijuana use (vs. no)
Past-year use 2.26 1.68e3.05 6.68 2.51e17.78 9.27 3.07e27.98 8.14 2.66e24.95
Nonmedical use of pain relievers, sedatives, tranquilizers (vs. no)
Past-year use 10.81 8.13e14.37 6.21 1.44e26.78 e 6.82 1.39e33.57
Survey year (vs. 2005)
2006 0.91 0.58e1.43 ed ed ed
2007 0.81 0.54e1.22 e e e
2008 0.93 0.59e1.45 e e e
2009 0.84 0.56e1.27 e e e
2010 0.87 0.54e1.40 e e e
2011 0.88 0.59e1.30 e e e
2012 1.47 1.09e1.99 e e e
Note: AOR: adjusted odds ratio; CI: conﬁdence interval. Because of a small number, results for Native Hawaiians/Paciﬁc Islanders are considered preliminary. The boldface
indicates P < 0.05.
a Each adjusted logistic regression included all variables listed in the ﬁrst column.
b Two older age groups (18e25, 26e34) were combined for Asian-Americans due to a small cell size; age was included as a continuous variable for native Hawaiians/Paciﬁc
Islanders due to a small cell size.
c The two groups (small metro, nonmetro) were combined due to a small cell size.
d The variables were not included in the model due to a small cell size. Due to the sample size, results for Native Hawaiians/Paciﬁc Islanders are considered preliminary.
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2005; Stevens et al., 2005).
Finally, results reveal female excess in past-year NMSU (Whites,
NHs/PIs, mixed-race individuals) and StiUD (mixed-race). Sex dif-
ferences in reasons for NMSU may contribute to this ﬁnding. Fe-
males may bemore likely thanmales to use prescription stimulants
to lose weight, study, or increase alertness, while males may be
more likely to use them to experiment with drug effects or coun-
teract effects of other drugs (Gritz and Crane, 1991; Teter et al.,
2006). The elevated prevalence in females also may be related to
a greater tendency to share or loan the drug (Daniel et al., 2003;
Petersen et al., 2008).
4.2. Limitations
NSDUH uses a cross-sectional design to provide national esti-
mates of drug use for the noninstitutionalized population. Results
reﬂect estimates and correlates of NMSU and StiUD, not causality.
The deﬁnition of NMSU includes heterogeneous groups of users,
ranging from sporadic to frequent use. For example, Asian-
Americans showed a low NMSU prevalence, but one in 8 (13%)
past-year Asian-American NMSUs met criteria for an NSDUH-
deﬁned StiUD. The problematic users can be the target for
focused intervention. The national NSDUH data cannot describecauses of NMSU and StiUD. Nonetheless, results of Asian-
Americans are consistent with those of Whites, indicating that
friends/relatives are primary sources of stimulants and that NMSU
is associated with other substance use, supporting the need to
extend drug use prevention research (e.g., peer inﬂuence,
perception of stimulant effects) to include Asian-Americans
(Looby et al., 2013). These ﬁndings are conservative estimates
given the potential of underreporting or undercoverage of subsets
of drug users. Like other national studies, NSDUH relies on re-
spondents' self-reports, which are inﬂuenced by memory errors
and underreporting. The survey does not assess ADHD and med-
ical stimulant use, which may inﬂuence NMSU (Rabiner et al.,
2009; Setlik et al., 2009). Although we analyzed a large national
sample, the population size of NHs/PIs is small (0.4%) and repre-
sents a challenge for research on this understudied population
(U.S. Census Bureau, 2011). The moderate sample (N ¼ 1729) of
NHs/PIs constrains analysis of NMSU and StiUD. Nonetheless, re-
sults present much needed data for NHs/PIs.
NSDUH has strengths. It is the largest U.S. study of drug use and
includes comprehensive assessments of NMSU status. NSDUH uses
detailed probes to augment substance use assessments, color pic-
tures of prescription drugs to aid identiﬁcation of drugs used, and
computer-assisted self-interviewing to ensure respondents' pri-
vacy; additionally, it implements rigorous procedures (consistency
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response inconsistency and adjust for nonresponse bias) to
enhance the data quality (Gfroerer et al., 2002; Harrison et al.,
2007; SAMHSA, 2013b).
4.3. Conclusion and clinical implications
As suggested by the ﬁnding that 13% of either White or Asian-
American NMSUs had an NSDUH-deﬁned StiUD, prescription
stimulants are considered to have an abuse potential and may lead
to dependence, and they are placed on scheduled II of Controlled
Substances by the U.S. Drug Enforcement Administration (DEA).
Stimulant use has side effects (e.g., trouble sleeping, mood swings)
and is associated with occurrences of circulation, heart-related
(stroke, increased blood pressure, sudden death), or psychiatric
events (behavioral, psychotic symptoms); individuals with such a
condition (including substance abuse) are not recommended for
taking stimulants (U.S. Food and Drug Administration, 2013). Ad-
olescents or young adults who use nonprescribed or diverted
stimulants place themselves at unnecessary risk for adverse effects
(Kaye and Darke, 2012; U.S. Food and Drug Administration, 2013).
The association between NMSU and other drug use suggests an
increased likelihood of adverse effects among substance-using
stimulant users (e.g., drug-related toxicity, escalation of behav-
ioral or psychiatric symptoms, healthcare visits) (Kaye and Darke,
2012; U.S. Food and Drug Administration, 2013). Regardless of pa-
tients' racial/ethnic status, physicians who prescribe stimulants
should educate patients (adolescents, young adults) and/or their
parents about potential adverse effects of inappropriate stimulant
use and proper disposal of unneeded medications (U.S. Food and
Drug Administration, 2014). The patients should be monitored for
signs of inappropriate stimulant use, misuse, or diversion
(Greydanus, 2006). The prevalence of past-year NMSU (<4%) sug-
gests that screening and intervention for stimulant-related prob-
lems or StiUD in medical setting can target potential risk
subgroups‒individuals manifesting conduct problems, depression,
or drug use‒to increase efﬁciency. Given the high prevalence of
drug use, healthcare providers should be aware of increased
numbers of youth with mixed cultural heritage and provide
screening for behavioral/mental problems and interventions as
needed. Finally, each Asian-American, NH/PI, or mixed-race popu-
lation is diverse in languages, cultural traditions, and socioeco-
nomic status, all of which can inﬂuence drug use (Macartney et al.,
2013; Wong et al., 2004). In-depth research is needed to further
disaggregate their drug use behaviors and consequences while
considering culture-speciﬁc contextual factors.
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